 MedPage Today |
Merck & Co's asthma drug Singulair faces US generic onslaught
PMLiVE The Food and Drug Administration (FDA) has approved the first generic versions of Merck & Co's blockbuster asthma and allergy drug Singulair. The US regulator granted ten companies licences to market their own version of Singulair (motelukast) for use … Israel : TEVA bags approval from FDA to market generic asthma treatment … New generic Singulair could save asthma sufferers big bucks Generic Singulair Approved |
View full post on asthma – Google News